Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Antimicrobial Resistance
62%
Infection
62%
Urinary Tract Infection
58%
Randomized Controlled Trial
50%
Chronic Obstructive Lung Disease
50%
Community Acquired Infection
50%
Antiinfective Agent
50%
Ecological Study
50%
Antibiotic Therapy
50%
Antibiotics
27%
Salmonellosis
16%
Bronchodilating Agent
16%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
12%
Mastitis
8%
Furunculosis
8%
Typhoid Fever
8%
Effectiveness Study
8%
Biological Marker
8%
Haemophilus Influenzae Type B
8%
Upper Respiratory Tract Infection
8%
Infectious Agent
8%
Microflora
8%
Soft Tissue Infection
8%
Abscess
8%
Pneumococcal Infection
8%
Staphylococcus aureus
8%
Peptoclostridium difficile
8%
Meningitis
8%
Skin Infection
8%
Campylobacter Enteritis
8%
Cefalexin
6%
Trimethoprim
6%
Amoxicillin
6%
Ciprofloxacin
6%
Nitrofurantoin
6%
Escherichia coli
6%
Medicine and Dentistry
Infection
62%
Systematic Review
50%
Community Acquired Infection
50%
Antiinfective Agent
50%
Antibiotic Resistance
50%
Antibiotic Therapy
50%
Observational Study
50%
Salmonellosis
16%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
12%
Abscess
8%
Pathogen
8%
Peptoclostridium difficile
8%
Staphylococcus Aureus
8%
Upper Respiratory Tract Infection
8%
Meningitis
8%
Haemophilus Influenzae Type B
8%
Mastitis
8%
Typhoid Fever
8%
Pneumococcal Infection
8%
Urinary Tract Infection
8%
Furunculosis
8%
Skin Infection
8%
Campylobacter Enteritis
8%
Antibiotics
8%
Soft Tissue Infection
8%
Environmental Factor
6%
Immunology and Microbiology
Eosinophil Count
50%
Gut Microbiome
50%
Eosinophil
50%
Antimicrobial Resistance
50%
Microbiome
40%
Bronchodilator
16%
Species Diversity
10%
Web of Science
10%
Juvenile Idiopathic Arthritis
10%
Species Composition
10%
Lactobacillus
10%
Bifidobacterium
10%
Crohn's Disease
10%
Escherichia coli
10%
Penicillin
10%
Asthma
10%
Proteobacteria
10%
